Dr Karen Long, consultant clinical psychologist and frontline service lead at Your Healthcare (Credit: Jo Thomas)
An NHS provider of ADHD and autism assessments found that an AI tool which records and summarises appointments…
Continue Reading
Top News
Ruthia He, founder and CEO of ADHD-prescribing site Done, is convicted on federal charges of illegally distributing Adderall, committing healthcare claims fraud, and conspiring to obstruct justice. The company’s clinical president,…
Continue Reading
Right to left: Louise Simpson, director of operations at Psicon, and Janelle Bierdeman, manager of healthcare solutions at MHS (Credit: Psicon and MHS)
In the face of rising demand for ADHD and autism spectrum…
Continue Reading
Image Credit: Revealense
What You Should Know:
– ARC, the innovation arm of the world-renowned Sheba Medical Center, and Revealense, a creator of a neurological-AI engine, have announced a joint venture.
– The collaboration will focus on…
Continue Reading
Top News
Ambient scribe technology vendor Nabla raises $70 million in a Series C funding round, increasing its total to $120 million.
The company will use the money to develop an agentic AI platform that will…
A new study from South Korea has demonstrated the use of AI models to possibly diagnose and stratify attention deficit hyperactivity disorder by analysing eye images.FINDINGS
Researchers from Yonsei University Health System have used four…
Explore how a leading provider of neurodevelopmental healthcare services revolutionized its referral process by integrating scientifically validated tools for ADHD and ASD into its established business systems. This case study highlights the significant advancements…
Continue Reading
Attention-deficit/hyperactivity disorder (ADHD), characterized by diagnostic complexity and symptom heterogeneity, is a prevalent neurodevelopmental disorder. Here, we explored the machine learning (ML) analysis of retinal fundus photographs as a noninvasive biomarker for ADHD screening…
Continue Reading
Birmingham Community Healthcare NHS Foundation Trust is piloting the CLEO SOLO electronic prescribing solution (EPS) in its children’s services.
The two-year pilot is planned to launch in March 2025 in community paediatrics and the ADHD…
A project to support young people with attention deficit and hyperactivity disorder (ADHD) has secured funding to develop a multilingual virtual assistant.
A collaboration between the Digital Futures Lab at Torbay and South Devon NHS…
